Michael AlscherNon-Executive Chair Read More
Michael AlscherNon-Executive Chair
Mr Michael Alscher has been Chair of ACL since its acquisition by Crescent Capital Partners (Crescent) in 2015.
Michael is the Managing Partner and founder of Crescent, a leading Australian private equity investment firm, specialising in high growth companies and certain industry sectors such as healthcare.
Michael is the current Chair of Cardno Limited, National Dental Care Limited, National Home Doctor Service Pty Ltd and is a Non-Executive Director of Clearview Wealth Limited. Michael’s former director roles include Chair of Cover-More Group Limited, LifeHealthcare Group Limited and Director of Metro Performance Glass Limited.
Prior to founding Crescent in 2000, Michael was a strategy consultant at Bain International and LEK Partnership as well as holding several senior operating roles.
As a result of his affiliation with Crescent, Michael is not considered to be an Independent Chair.
Michael holds a Bachelor of Commerce (Finance and Mathematics) Degree from the University of New South Wales.
Melinda McGrathChief Executive Officer and Executive Director Read More
Melinda McGrathChief Executive Officer and Executive Director
Ms Melinda McGrath has been the Chief Executive Officer and Executive Director of ACL since 2015. Melinda has more than 30 years’ experience in healthcare with over 20 years of experience in chief executive roles and over 13 years of experience in pathology CEO roles.
Melinda has played a lead role in the organisation’s transformation, building ACL’s scale and operational performance improvement over the past six years, overseeing the integration of Healthscope’s Australian pathology business, St John of God Health Care’s pathology business, Perth Pathology and SunDoctors. She has also driven the establishment of one performance oriented culture across the organisation, via one unified integrated pathology system.
Melinda was Chief Executive Officer of QML Pathology (part of Healius) from 2008 to 2015, where she developed five QML brands and established Tasmania Medical Laboratories. Prior to that, Melinda held various chief executive roles at private regional and tertiary referral hospitals in Queensland including The Sunshine Coast Private Hospital, St Andrew’s War Memorial Hospital and St Stephens Private Hospital.
Melinda has held board member positions at Metro North Hospitals and Health Service including Royal Brisbane, Prince Charles, Redcliffe, Caboolture and related health services, and a superannuation fund, UC Super.
Melinda holds a Bachelor of Human Movement Studies Degree and a Bachelor of Arts Degree from the University of Queensland, a Master of Business Administration from the University of Central Queensland, and a Certificate in Governance Practice from the Governance Institute of Australia.
Nathanial ThomsonNon-Executive Director Read More
Nathanial ThomsonNon-Executive Director
Mr Nathanial Thomson has been a Non-Executive Director of ACL since April 2018.
Nathanial is a Partner at Crescent, a leading Australian private equity investment firm. Nathanial has over 20 years of experience in strategy consulting, private equity and investment banking. He has significant consulting experience from his prior role at McKinsey & Co. where he worked with clients across the financial industry.
Nathanial is a current Director of Cardno Limited, National Dental Care Limited, Clearview Wealth Limited and National Home Doctor Service Pty Ltd. Nathanial’s former director roles include Deputy Chair of Cover-More Group Limited and a Non-Executive Director of Metro Performance Glass Limited.
As a result of his affiliation with Crescent, Nathanial is not considered to be an Independent Director.
Nathanial holds a Bachelor of Commerce Degree and Bachelor of Laws Degree from The University of Western Australia.
Andrew DuttonIndependent Non-Executive Director & Chair of the Remuneration and Nomination Committee Read More
Andrew DuttonIndependent Non-Executive Director & Chair of the Remuneration and Nomination Committee
Mr Andrew Dutton has been a Non-Executive Director of ACL since 28 April 2021.
Mr Andrew Dutton has 30 years of management, business development and technology experience across Australia, Asia and Europe.
Andrew is the current Chair of Land Registry Services and was recently an Advisor to FinancialForce APJ. He has had extensive Chief Executive Officer and Board experience globally and within Australia.
Andrew’s former roles include Chair of NVOI Pty Ltd and SAI Global Pty Ltd; Chief Executive Officer at Land Registry Services and Integrated Research Limited; Managing Director of the Asia Pacific/Japan region for VMware Inc.; senior executive positions at IBM, Computer Associates, BEA Systems Inc., Lend Lease and Norwich Union Financial Services Group including roles as CFO, CMO, CRO and Divisional Heads. At IBM, Andrew was elected to the Worldwide Senior Leadership Team.
Andrew holds a Bachelor of Science Degree from The University of Sydney and is a member of the Australian Institute of Company Directors.
Dr Leanne Rowe AMIndependent Non-Executive Director Read More
Dr Leanne Rowe AMIndependent Non-Executive Director
Dr Leanne Rowe has been a Non-Exective Director of ACL since 28 April 2021.
Dr Leanne Rowe is a clinical professor and medical practitioner with over 30 years of clinical experience in the public and private health systems across acute care, aged care, mental health and community health.
Leanne is currently Chair of Nexus Hospitals and a Non-Executive Director of Japara Healthcare Limited, Doctor Care Anywhere Group PLC, the Medical Indemnity Protection Society and MIPS Insurance. Previously she was Chair of the Royal Australian College of General Practitioners and a Non-Executive Director of Medibank Private, I-MED Radiology Network, GMHBA, Australian Health Management, Barwon Health and Beyond Blue.
Leanne is a former Deputy Chancellor of Monash University and has been awarded a Doctor of Laws (Honoris Causa) for her services. Leanne has also received a Member of the Order of Australia for her services to medicine and is a Fellow of the Royal Australian College of General Practitioners and the Australian Institute of Company Directors.
Leanne holds a Doctor of Laws (Honoris Causa), Doctor of Medicine and a Bachelor of Medicine Degree and Bachelor of Surgery Degree from Monash University.
Dr Michael Stanford AMIndependent Non-Executive Director & Chair of the Risk Committee Read More
Dr Michael Stanford AMIndependent Non-Executive Director & Chair of the Risk Committee
Dr Michael Stanford has been a Non-Executive Director of ACL since 28 April 2021.
Dr Michael Stanford has over 25 years of Non-Executive Director experience across a range of industries including healthcare services, diagnostics, biotech, pharmaceutical, property, aged care and higher education.
Michael is the current Chair of Diabetes Australia, an Independent Non-Executive Director of NorthWest Healthcare Property Management Limited and Nucleus Network Limited, and a Senior Advisor at Medibank Private Limited.
Michael’s former roles include Non-Executive Director for Clinical Labs between 2016 and 2019, Healthscope Limited, Virtus Health Limited, and Deputy Chancellor of Curtin University. He was in Group Chief Executive Officer roles for 23 years including 16 years at St John of God Health Care. Michael has also received a Member of the Order of Australia for his service to the health sector to tertiary education and in the community of Western Australia.
Michael holds a Bachelor of Medicine Degree and Bachelor of Surgery Degree from the University of New South Wales and a Master of Business Administration from Macquarie University. Michael is also a fellow of the Australasian Institute of Company Directors and was formerly a specialist in public health medicine.
Mark HaberlinIndependent Non-Executive Director & Chair of the Audit Committee Read More
Mark HaberlinIndependent Non-Executive Director & Chair of the Audit Committee
Mr Mark Haberlin has been a Non-Executive Director of ACL since 28 April 2021.
Mark has over 25 years of audit, risk management, capital transactions and mergers and acquisitions experience across industries including healthcare, real estate and financial services.
Mark is the Lead Independent Director and Chair of the Audit & Risk Committee of Abacus Property Group. Mark is also an Independent Non-Executive Director and the Chair of the Audit & Risk Committee of Laybuy Group Limited. Previously, Mark was the Chair of PwC Australia and PwC’s Public Reporting Panel, as well as a Director of the European Australia Business Council and PwC Asia Pacific.
Mark holds a Bachelor of Science (Civil Engineering) (Honours) from Imperial College London and qualified as a Chartered Accountant in the United Kingdom.